ArticleCureus2021

Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis.

Mehreen Inam Illahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.